Production (Stage)
Galmed Pharmaceuticals Ltd.
GLMD
$1.61
-$0.07-4.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.73M | 15.33M | 9.82M | 9.82M | 10.81M |
| Total Receivables | 447.00K | 209.00K | 135.00K | 135.00K | 254.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 463.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 122.00K | 121.00K | 118.00K | 118.00K | 117.00K |
| Total Current Assets | 16.30M | 16.12M | 10.08M | 10.08M | 11.18M |
|
|
|||||
| Total Current Assets | 16.30M | 16.12M | 10.08M | 10.08M | 11.18M |
| Net Property, Plant & Equipment | -- | 0.00 | -- | -- | 74.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 267.00K | 257.00K | -- | -- | -- |
| Total Assets | 18.68M | 18.50M | 13.34M | 13.34M | 14.52M |
|
|
|||||
| Total Accounts Payable | 1.31M | 1.31M | 1.20M | 1.20M | 1.38M |
| Total Accrued Expenses | -- | 859.00K | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 499.00K | 6.00K | 351.00K | 351.00K | 382.00K |
| Total Other Current Liabilities | 499.00K | 6.00K | 351.00K | 351.00K | 382.00K |
| Total Current Liabilities | 1.81M | 2.17M | 1.55M | 1.55M | 1.77M |
|
|
|||||
| Total Current Liabilities | 1.81M | 2.17M | 1.55M | 1.55M | 1.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.81M | 2.17M | 1.55M | 1.55M | 1.77M |
|
|
|||||
| Common Stock & APIC | 218.85M | 217.21M | 207.57M | 207.57M | 207.44M |
| Retained Earnings | -201.57M | -200.47M | -195.35M | -195.35M | -194.23M |
| Treasury Stock & Other | -397.00K | -416.00K | -435.00K | -435.00K | -455.00K |
| Total Common Equity | 16.88M | 16.33M | 11.79M | 11.79M | 12.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.88M | 16.33M | 11.79M | 11.79M | 12.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.88M | 16.33M | 11.79M | 11.79M | 12.76M |
|
|
|||||